Oramed Pharmaceuticals
ORMP
#9145
Rank
โ‚ฌ0.15 B
Marketcap
3,54ย โ‚ฌ
Share price
5.12%
Change (1 day)
75.88%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): โ‚ฌ53.41 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of โ‚ฌ56.56 Million, an increase over its 2024 earnings that were of -โ‚ฌ13.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ53.41 M-5.57%
2025 โ‚ฌ56.56 M-513.21%
2024 -โ‚ฌ13.69 Million-311.47%
2023 โ‚ฌ6.47 M-119.45%
2022 -โ‚ฌ33.28 Million39.17%
2021 -โ‚ฌ23.92 Million73.93%
2020 -โ‚ฌ13.75 Million18.53%
2019 -โ‚ฌ11.6 Million-16.62%
2018 -โ‚ฌ13.92 Million38.32%
2017 -โ‚ฌ10.06 Million12.51%
2016 -โ‚ฌ8.94 Million25.01%
2015 -โ‚ฌ7.15 Million18.18%
2014 -โ‚ฌ6.06 Million39.72%
2013 -โ‚ฌ4.34 Million46.4%
2012 -โ‚ฌ2.96 Million128.32%
2011 -โ‚ฌ1.3 Million-51.47%
2010 -โ‚ฌ2.67 Million35.21%
2009 -โ‚ฌ1.98 Million
2007 -โ‚ฌ3.11 Million607.04%
2006 -โ‚ฌ0.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚ฌ20.88 B 36,485.33%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚ฌ7.07 B 12,296.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.41 Billion-811.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚ฌ55.53 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ31.69 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel